SE425733B - Forfarande for framstellning av vissa angivna triglyucerider med antiinflammatoriska egenskaper - Google Patents

Forfarande for framstellning av vissa angivna triglyucerider med antiinflammatoriska egenskaper

Info

Publication number
SE425733B
SE425733B SE7512421A SE7512421A SE425733B SE 425733 B SE425733 B SE 425733B SE 7512421 A SE7512421 A SE 7512421A SE 7512421 A SE7512421 A SE 7512421A SE 425733 B SE425733 B SE 425733B
Authority
SE
Sweden
Prior art keywords
triglyucerides
procedure
inflammatory properties
preparing certain
certain stated
Prior art date
Application number
SE7512421A
Other languages
English (en)
Swedish (sv)
Other versions
SE7512421L (sv
Inventor
G Y Paris
D L Garmaise
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of SE7512421L publication Critical patent/SE7512421L/xx
Publication of SE425733B publication Critical patent/SE425733B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7512421A 1974-11-07 1975-11-05 Forfarande for framstellning av vissa angivna triglyucerider med antiinflammatoriska egenskaper SE425733B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/521,727 US3988446A (en) 1974-11-07 1974-11-07 Glycerides with anti-inflammatory properties

Publications (2)

Publication Number Publication Date
SE7512421L SE7512421L (sv) 1976-05-10
SE425733B true SE425733B (sv) 1982-11-01

Family

ID=24077893

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7512421A SE425733B (sv) 1974-11-07 1975-11-05 Forfarande for framstellning av vissa angivna triglyucerider med antiinflammatoriska egenskaper

Country Status (11)

Country Link
US (1) US3988446A (da)
JP (1) JPS5165706A (da)
CA (1) CA1067488A (da)
CH (1) CH601167A5 (da)
DE (1) DE2549783C3 (da)
DK (1) DK154287C (da)
FR (1) FR2290189A1 (da)
GB (1) GB1490603A (da)
NL (1) NL161499C (da)
SE (1) SE425733B (da)
ZA (1) ZA756196B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150125A (en) * 1977-09-30 1979-04-17 Abbott Laboratories Triglyceride ester of phosphonoacetic acid having antiviral activity
US4178299A (en) * 1978-03-27 1979-12-11 Abbott Laboratories Process for preparing 1,3-diacyl glycerols
JPS5935941B2 (ja) * 1979-04-02 1984-08-31 株式会社資生堂 紫外線吸収剤
CA1176644A (en) * 1982-03-24 1984-10-23 Neil E. Bateman Pharmaceutical compound and process for the manufacture thereof
US4546197A (en) * 1982-03-24 1985-10-08 R. P. Scherer Corporation Pharmaceutical composition and process for the manufacture thereof
US4607052A (en) * 1983-04-15 1986-08-19 Roussel-Uclaf Triglycerides, dietetic and therapeutical applications and compositions containing them
US4701469A (en) * 1983-04-15 1987-10-20 Roussel Uclaf Triglycerides, process for therapeutical applications and compositions containing them
AU7872491A (en) * 1990-05-07 1991-11-27 Vical, Inc. Lipid prodrugs of salicylate and nonsteroidal anti-inflammatory drugs
JP3828147B2 (ja) * 1994-04-19 2006-10-04 株式会社カネカ トリアゾール誘導体の製造法
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
WO2005018632A1 (en) 2003-08-18 2005-03-03 Btg International Limited Treatment of neurodegenerative conditions
GB0425658D0 (en) * 2004-11-22 2004-12-22 Stanford Rook Ltd Immunotherapeutic agent
JP5470672B2 (ja) * 2004-12-09 2014-04-16 コニカミノルタ株式会社 セルロースエステルフィルムの製造方法
GB0504362D0 (en) 2005-03-02 2005-04-06 Btg Int Ltd Cytokine modulators
US20100104625A1 (en) * 2007-02-16 2010-04-29 Cornell University Biodegradable compositions and materials
WO2018115984A1 (en) 2016-12-19 2018-06-28 Cellix Bio Private Limited Compositions and methods for the treatment of inflammation
EP4262778A1 (en) * 2020-12-21 2023-10-25 The Research Foundation for The State University of New York Penetrating cryoprotection agents and methods of making and using same
CN112516129B (zh) * 2021-01-09 2022-04-29 兰州大学 反式1,3-二亚油精在制备治疗胃癌药物、健胃药物、保健品和食品中的应用
CN112500288B (zh) * 2021-01-09 2023-02-03 兰州大学 一种反式1,3-二亚油精的制备方法
CN112746854B (zh) * 2021-02-22 2023-04-28 核工业井巷建设集团有限公司 一种适用于顶管机的防管节抱死的注浆结构和一种顶管机

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3119739A (en) * 1961-05-03 1964-01-28 Wanda L Campbell Acetylmethyl-salicylate for pain relief
US3279990A (en) * 1963-01-31 1966-10-18 Jacobs Albert L Carbohydrate esters of salicylic acid, their production and administration
GB1080470A (en) * 1963-12-31 1967-08-23 Merck & Co Inc Indole derivatives
CH500973A (de) * 1966-10-31 1970-12-31 Ciba Geigy Ag Verfahren zur Herstellung neuer Derivate von Phenylessigsäuren
US3468907A (en) * 1967-04-10 1969-09-23 Schering Corp Glyceryl esters of alpha-(1-aroyl-3-indolyl)alkanoic acids
US3652609A (en) * 1969-06-24 1972-03-28 American Home Prod 2-parachlorophenoxy-2-methylpropionic acid-fatty acid glycerides
US3644424A (en) * 1969-10-16 1972-02-22 Schering Corp Glyceryl acetylsalicylate and its analgesic anti-inflammatory use
DE2004098B2 (de) * 1970-01-30 1978-09-14 Dynamit Nobel Ag, 5210 Troisdorf Nichtspröde, partialesterfreie Suppositorienmassen und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
ZA756196B (en) 1976-09-29
CA1067488A (en) 1979-12-04
GB1490603A (en) 1977-11-02
DK154287C (da) 1989-04-17
FR2290189B1 (da) 1980-11-21
US3988446A (en) 1976-10-26
NL161499B (nl) 1979-09-17
DE2549783B2 (de) 1979-06-07
DK154287B (da) 1988-10-31
FR2290189A1 (fr) 1976-06-04
DK499875A (da) 1976-05-08
JPS5165706A (en) 1976-06-07
NL161499C (nl) 1980-02-15
CH601167A5 (da) 1978-06-30
NL7512376A (nl) 1976-05-11
DE2549783C3 (de) 1980-03-20
JPS568820B2 (da) 1981-02-25
SE7512421L (sv) 1976-05-10
DE2549783A1 (de) 1976-05-20
AU8541975A (en) 1977-04-07

Similar Documents

Publication Publication Date Title
SE423633B (sv) Forfarande for framstellning av 4-demetoxi-daunomycin
SE428562B (sv) Forfarande for framstellning av purinderivat
SE425733B (sv) Forfarande for framstellning av vissa angivna triglyucerider med antiinflammatoriska egenskaper
SE419605B (sv) Forfarande for framstellning av undertrycksformad gjutform
SE7513085L (sv) Forfarande for framstellning av etrar
SE7511408L (sv) Forfarnde for framstellning av karbamid- eller tiokarbamidderivat
SE431211B (sv) Forfarande for framstellning av n-acylamino-alfa-arylacetamido-cefalosporiner
SE412066B (sv) Forfarande for framstellning av famakologiskt verksamma tienodiazinderivat
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE421209B (sv) Analogiforfarande for framstellning av tienobensodiazepiner
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE421612B (sv) Forfarande for framstellning av alfa-6-deoxi-5-hydroxitetracyklin
SE422052B (sv) Forfarande for framstellning av vissa angivna 1-fenoxi-2-hydroxi-3-aminofenyl-propylderivat
NO143625C (no) Analogifremgangsmaate for fremstilling av 2-metoksy-benzamider
SE425739B (sv) Forfarande for framstellning av vissa angivna tetrazolyl-bensopyranopyridinderivat
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
SE7506827L (sv) Forfarande for framstellning av nitrilhaltig polymer
SE414926B (sv) Forfarande for framstellning av 1-alkyl-2-(fenoximetyl)-5-nitroimidazoler
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE404364B (sv) Forfarande for framstellning av vissa angivna 5-sulfonylfenyl-tetrazolderivat
SE421310B (sv) Forfarande for framstellning av substituerade bensoylpyridiner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7512421-4

Effective date: 19891114

Format of ref document f/p: F